Build Growth by Increasing Credibility

What if you could have a clinical platform that reduced the cost for patients, simplified the patient process, and captured all the data necessary to treat them?

Well, that is exactly what Ed Seguine, CEO of Clinical Ink created. With this platform in its clinical trial period, Mr. Seguine saw double the sales and immediate success from this launch.?

In an interview with Ashton Tweed, Mr. Seguine discusses his strategy for navigating the financial and operational challenges of rapid growth.

“Clinical Ink’s real defining moment was to shift all of that activity to what I characterize as “the moment that matters” during the patient visit. If you can do all that work during the moment that matters, you can have an impact on the execution of a protocol and on the clinical decision-making right then.”

Find out what else he had to say - bit.ly/3wL2BUz

Improving Supply Chain Processes

When the pandemic hit we saw a huge shortage in the medical supply chain, with medical equipment and devices becoming scarce and hard to track.?

This situation gave manufacturers the push to think outside of the box when it came to the production of goods in the US. This spurred a host of innovative changes in how we handle medical data and technology. Now you can track inventory and vaccine distribution through technology such as digital health and AI.

Improved technology has made it easier for providers to match the demand and address shortages.